2023
Publications
Publications
Browse recent publications with filters for title, author, journal, and year.
2023
Repurposing immunosuppressants for antileukemia therapy
2023
Editorial: Novel perspectives on the NLRP3 inflammasome
2022
Excessive IL-10 and IL-18 trigger hemophagocytic lymphohistiocytosis-like hyperinflammation and enhanced myelopoiesis
2021
Tumor Microenvironment-Derived R-spondins Enhance Antitumor Immunity to Suppress Tumor Growth and Sensitize for Immune Checkpoint Blockade Therapy
2021
Germline variants in UNC13D and AP3B1 are enriched in COVID-19 patients experiencing severe cytokine storms
2021
Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention
2021
Innate immune responses in RNA viral infection
2021
STAT3 and STAT5B mutations have unique distribution in T-cell large granular lymphocyte proliferations and advanced myeloid neoplasms
2021
Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity
2021
Protein S-nitrosylation regulates proteostasis and viability of hematopoietic stem cell during regeneration
2021
VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder
2021
Molecular and clinical features of myeloid neoplasms with somatic DDX41 mutations
2021
Benzene induces rapid leukemic transformation after prolonged hematotoxicity in a murine model
2021
Adaptive responses to mTOR gene targeting in hematopoietic stem cells reveal a proliferative mechanism evasive to mTOR inhibition
2021
Arsenic Dispensing Powder Promotes Erythropoiesis in Myelodysplastic Syndromes via Downregulation of HIF1A and Upregulation of GATA Factors
2021
Dynamics of Blood Viral Load Is Strongly Associated with Clinical Outcomes in Coronavirus Disease 2019 (COVID-19) Patients: A Prospective Cohort Study
2020
Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients
2020
Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centre
2020
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
2020
Mutational features of myelodysplastic syndromes with Auer rods reveal them are more akin to acute myeloid leukemia
2020
The Clinical, Molecular, and Mechanistic Basis of RUNX1 Mutations Identified in Hematological Malignancies
2020
The Role of RUNX1 in NF1-Related Tumors and Blood Disorders
2020
DNMT3A mutants provide proliferating advantage with augmentation of self-renewal activity in the pathogenesis of AML in KMT2A-PTD-positive leukemic cells
2020